Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Carr

Showing results (421-430 of 461) with videos related to

Pageof 47
Sort By:
Medical and Pediatric Oncology|January 1, 1983
Continuous five-day infusion of PALA and 5FU: a pilot phase II trialC A Presant, B Ardalan, P Multhauf, et al.
Pediatric Radiology|December 2, 2000
Intrahepatic chemoembolization in unresectable pediatric liver malignanciesC M Arcement, R B Towbin, M P Meza, et al.
Journal of Hepatology|October 1, 1994
The use of granulocyte-macrophage colony-stimulating factor to enhance hematologic parameters of patients with cirrhosis and hypersplenismA Gurakar, S Fagiuoli, J S Gavaler, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 14, 2007
Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experienceNiraj J Gusani, Fady K Balaa, Jennifer L Steel, et al.
Journal of Occupational and Environmental Medicine|May 29, 2004
Characteristics of hepatocellular carcinoma in a high arsenicism area in Taiwan: a case-control studySheng-Nan Lu, Nan-Haw Chow, Wen-Chih Wu, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 17, 2005
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysisJames E Goin, Riad Salem, Brian I Carr, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 17, 2005
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicitiesJames E Goin, Riad Salem, Brian I Carr, et al.
Scientific Reports|June 10, 2021
DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemiaEric Haines, Yuki Nishida, Michael I Carr, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 28, 2006
Immunostimulatory principles from Chlorella pyrenoidosa--part 1: isolation and biological assessment in vitroJ A Kralovec, K L Metera, J R Kumar, et al.
Hepatology (Baltimore, Md.)|August 1, 1997
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot studyJ W Marsh, I Dvorchik, M Subotin, et al.
Pageof 47

Showing results (421-430 of 461) with videos related to

Sort By:
Pageof 47
Medical and Pediatric Oncology|January 1, 1983
Continuous five-day infusion of PALA and 5FU: a pilot phase II trialC A Presant, B Ardalan, P Multhauf, et al.
Pediatric Radiology|December 2, 2000
Intrahepatic chemoembolization in unresectable pediatric liver malignanciesC M Arcement, R B Towbin, M P Meza, et al.
Journal of Hepatology|October 1, 1994
The use of granulocyte-macrophage colony-stimulating factor to enhance hematologic parameters of patients with cirrhosis and hypersplenismA Gurakar, S Fagiuoli, J S Gavaler, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 14, 2007
Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experienceNiraj J Gusani, Fady K Balaa, Jennifer L Steel, et al.
Journal of Occupational and Environmental Medicine|May 29, 2004
Characteristics of hepatocellular carcinoma in a high arsenicism area in Taiwan: a case-control studySheng-Nan Lu, Nan-Haw Chow, Wen-Chih Wu, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 17, 2005
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysisJames E Goin, Riad Salem, Brian I Carr, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 17, 2005
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicitiesJames E Goin, Riad Salem, Brian I Carr, et al.
Scientific Reports|June 10, 2021
DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemiaEric Haines, Yuki Nishida, Michael I Carr, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 28, 2006
Immunostimulatory principles from Chlorella pyrenoidosa--part 1: isolation and biological assessment in vitroJ A Kralovec, K L Metera, J R Kumar, et al.
Hepatology (Baltimore, Md.)|August 1, 1997
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot studyJ W Marsh, I Dvorchik, M Subotin, et al.
Pageof 47